{"id":"https://openalex.org/W4405041996","doi":"https://doi.org/10.1182/blood-2024-204614","title":"First-in-Human Phase 1 Study of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Non-Hodgkin Lymphoma","display_name":"First-in-Human Phase 1 Study of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Non-Hodgkin Lymphoma","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405041996","doi":"https://doi.org/10.1182/blood-2024-204614"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-204614","doi":"https://doi.org/10.1182/blood-2024-204614","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-204614","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078740906","display_name":"Fredrik Hellem Schjesvold","orcid":"https://orcid.org/0000-0003-1096-0569","observed_orcids":["https://orcid.org/0000-0003-1096-0569"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Fredrik Schjesvold","raw_affiliation_strings":["1Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078353739","display_name":"Tom\u00e1\u0161 Jel\u0131\u0301nek","orcid":"https://orcid.org/0000-0002-5467-9253","observed_orcids":["https://orcid.org/0000-0002-5467-9253"]},"institutions":[{"id":"https://openalex.org/I187293425","display_name":"University of Ostrava","ror":"https://ror.org/00pyqav47","country_code":"CZ","type":"education","lineage":["https://openalex.org/I187293425"]},{"id":"https://openalex.org/I4210088935","display_name":"University Hospital Ostrava","ror":"https://ror.org/00a6yph09","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210088935"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Tomas Jelinek","raw_affiliation_strings":["2Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic","institution_ids":["https://openalex.org/I187293425","https://openalex.org/I4210088935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036950995","display_name":"Kamila Polg\u00e1rov\u00e1","orcid":"https://orcid.org/0000-0003-2822-1692","observed_orcids":["https://orcid.org/0000-0003-2822-1692"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Kamila Polgarova","raw_affiliation_strings":["3First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112385709","display_name":"Lud\u011bk Pour","orcid":"https://orcid.org/0000-0002-6274-7009","observed_orcids":["https://orcid.org/0000-0002-6274-7009"]},"institutions":[{"id":"https://openalex.org/I21449261","display_name":"Masaryk University","ror":"https://ror.org/02j46qs45","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21449261"]},{"id":"https://openalex.org/I4210102302","display_name":"University Hospital Brno","ror":"https://ror.org/00qq1fp34","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210102302"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"Ludek Pour","raw_affiliation_strings":["4Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic","institution_ids":["https://openalex.org/I21449261","https://openalex.org/I4210102302"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102778771","display_name":"Sung Soo Yoon","orcid":"https://orcid.org/0000-0001-7970-215X","observed_orcids":["https://orcid.org/0000-0001-7970-215X"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sung-Soo Yoon","raw_affiliation_strings":["5Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042235090","display_name":"Won Gu Kim","orcid":"https://orcid.org/0000-0002-8404-7759","observed_orcids":["https://orcid.org/0000-0002-8404-7759"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Won Seog Kim","raw_affiliation_strings":["6Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055817555","display_name":"Alexander Foss\u00e5","orcid":"https://orcid.org/0000-0002-4484-9319","observed_orcids":["https://orcid.org/0000-0002-4484-9319"]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Alexander Foss\u00e5","raw_affiliation_strings":["7Department of Oncology, Oslo University Hospital, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Oncology, Oslo University Hospital, Oslo, Norway","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020989412","display_name":"Jes\u00fas F. San Miguel","orcid":"https://orcid.org/0000-0002-9183-4857","observed_orcids":["https://orcid.org/0000-0002-9183-4857"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]},{"id":"https://openalex.org/I4392738196","display_name":"Centro de Investigaci\u00f3n M\u00e9dica Aplicada","ror":"https://ror.org/01qew8q20","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4392738196","https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jes\u00fas F. San-Miguel","raw_affiliation_strings":["8Cancer Center Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Cancer Center Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003","https://openalex.org/I4392738196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047288670","display_name":"Miguel \u00c1ngel Canales","orcid":"https://orcid.org/0000-0002-6550-2621","observed_orcids":["https://orcid.org/0000-0002-6550-2621"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Miguel Canales","raw_affiliation_strings":["9Cancer Center Clinica Universidad de Navarra, Pamplona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Cancer Center Clinica Universidad de Navarra, Pamplona, Spain","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080959881","display_name":"Paula Rodr\u00edguez\u2010Otero","orcid":"https://orcid.org/0000-0001-5236-7785","observed_orcids":["https://orcid.org/0000-0001-5236-7785"]},"institutions":[{"id":"https://openalex.org/I88155538","display_name":"Universidad de Navarra","ror":"https://ror.org/02rxc7m23","country_code":"ES","type":"education","lineage":["https://openalex.org/I88155538"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Paula Rodr\u00edguez-Otero","raw_affiliation_strings":["10Clinica Universidad de Navarra, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Clinica Universidad de Navarra, Madrid, Spain","institution_ids":["https://openalex.org/I88155538"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054952877","display_name":"Albert Oriol","orcid":"https://orcid.org/0000-0001-6804-2221","observed_orcids":["https://orcid.org/0000-0001-6804-2221"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Albert Oriol","raw_affiliation_strings":["11Hematology, Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Hematology, Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032722606","display_name":"Javier de la Rubia","orcid":"https://orcid.org/0000-0002-8354-768X","observed_orcids":["https://orcid.org/0000-0002-8354-768X"]},"institutions":[{"id":"https://openalex.org/I3019010403","display_name":"Hospital Universitari i Polit\u00e8cnic La Fe","ror":"https://ror.org/01ar2v535","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I3019010403","https://openalex.org/I4210166036"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier de la Rubia","raw_affiliation_strings":["12Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain","institution_ids":["https://openalex.org/I3019010403"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034182883","display_name":"Joaqu\u00edn Mart\u00ednez\u2010L\u00f3pez","orcid":"https://orcid.org/0000-0001-7908-0063","observed_orcids":["https://orcid.org/0000-0001-7908-0063"]},"institutions":[{"id":"https://openalex.org/I121748325","display_name":"Universidad Complutense de Madrid","ror":"https://ror.org/02p0gd045","country_code":"ES","type":"education","lineage":["https://openalex.org/I121748325"]},{"id":"https://openalex.org/I4210101691","display_name":"Hospital Universitario 12 De Octubre","ror":"https://ror.org/00qyh5r35","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210101691","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joaqu\u00edn Mart\u00ednez-Lopez","raw_affiliation_strings":["13Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Department of Hematology, Hospital Universitario 12 de Octubre, CNIO, Universidad Complutense de Madrid, Madrid, Spain","institution_ids":["https://openalex.org/I121748325","https://openalex.org/I4210101691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074962085","display_name":"Sonia Gonz\u00e1lez de Villambros\u00eda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]},{"id":"https://openalex.org/I4210113075","display_name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla","ror":"https://ror.org/025gxrt12","country_code":"ES","type":"other","lineage":["https://openalex.org/I13134134","https://openalex.org/I4210113075"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sonia Gonz\u00e1lez De Villambrosia","raw_affiliation_strings":["14Hematology Department, Hospital Universitario Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Hematology Department, Hospital Universitario Marqu\u00e9s de Valdecilla (IDIVAL), Santander, Spain","institution_ids":["https://openalex.org/I4210099858","https://openalex.org/I4210113075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033220547","display_name":"Prashant Kapoor","orcid":"https://orcid.org/0000-0002-4342-364X","observed_orcids":["https://orcid.org/0000-0002-4342-364X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prashant Kapoor","raw_affiliation_strings":["15Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082004555","display_name":"Ola Landgren","orcid":"https://orcid.org/0000-0001-6485-4839","observed_orcids":["https://orcid.org/0000-0001-6485-4839"]},"institutions":[{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ola Landgren","raw_affiliation_strings":["16Sylvester Comprehensive Cancer Center, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Sylvester Comprehensive Cancer Center, Miami, FL","institution_ids":["https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102914339","display_name":"James Edward Hoffman","orcid":"https://orcid.org/0009-0003-8663-7001","observed_orcids":["https://orcid.org/0009-0003-8663-7001"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]},{"id":"https://openalex.org/I4210157065","display_name":"Sylvester Comprehensive Cancer Center","ror":"https://ror.org/0552r4b12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I145608581","https://openalex.org/I4210101935","https://openalex.org/I4210157065"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Edward Hoffman","raw_affiliation_strings":["17Sylvester Comprehensive Cancer Center, Myeloma Service, University of Miami, Miami, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17Sylvester Comprehensive Cancer Center, Myeloma Service, University of Miami, Miami, FL","institution_ids":["https://openalex.org/I145608581","https://openalex.org/I4210157065"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052048627","display_name":"Noopur S Raje","orcid":"https://orcid.org/0000-0003-3066-1275","observed_orcids":["https://orcid.org/0000-0003-3066-1275"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noopur Raje","raw_affiliation_strings":["18Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101784375","display_name":"Hongfang Wang","orcid":"https://orcid.org/0000-0002-1104-1540","observed_orcids":["https://orcid.org/0000-0002-1104-1540"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongfang Wang","raw_affiliation_strings":["19Sanofi R&D, North America, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19Sanofi R&D, North America, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021708643","display_name":"Kunal Jhunjhunwala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kunal Jhunjhunwala","raw_affiliation_strings":["20Sanofi, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"20Sanofi, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101780128","display_name":"Liang Zhao","orcid":"https://orcid.org/0000-0002-1429-0884","observed_orcids":["https://orcid.org/0000-0002-1429-0884"]},"institutions":[{"id":"https://openalex.org/I4210136746","display_name":"Sanofi (China)","ror":"https://ror.org/03pn9bd47","country_code":"CN","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210136746"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Liang Zhao","raw_affiliation_strings":["21Sanofi, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Sanofi, Shanghai, China","institution_ids":["https://openalex.org/I4210136746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087319645","display_name":"Zhini Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136746","display_name":"Sanofi (China)","ror":"https://ror.org/03pn9bd47","country_code":"CN","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210136746"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhini Wang","raw_affiliation_strings":["21Sanofi, Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Sanofi, Shanghai, China","institution_ids":["https://openalex.org/I4210136746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052898113","display_name":"Mony Morisse","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mony Morisse","raw_affiliation_strings":["20Sanofi, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"20Sanofi, Cambridge, MA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049970120","display_name":"Helgi J. Van de Velde","orcid":"https://orcid.org/0009-0004-4126-8289","observed_orcids":["https://orcid.org/0009-0004-4126-8289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helgi Van de Velde","raw_affiliation_strings":["19Sanofi R&D, North America, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19Sanofi R&D, North America, Cambridge, MA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040738036","display_name":"Nitya Nathwani","orcid":"https://orcid.org/0000-0003-4329-8102","observed_orcids":["https://orcid.org/0000-0003-4329-8102"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitya Nathwani","raw_affiliation_strings":["22Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"22Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":26,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"1992","last_page":"1992"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trispecific-antibodies","display_name":"trispecific antibodies","score":0.972000002861023},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.9010000228881836},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cd28","display_name":"CD28","score":0.9959999918937683},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9440000057220459},{"id":"https://openalex.org/keywords/relapsed-refractory-non-hodgkin-lymphoma","display_name":"relapsed/refractory non-Hodgkin lymphoma","score":0.9570000171661377},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.4869999885559082},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9819999933242798},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.693574070930481},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6078620553016663},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.5937583446502686},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5443480014801025},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.510358989238739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5065768957138062},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4990231990814209},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.4707237780094147},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.4652142822742462},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34924745559692383},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13373100757598877},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-204614","doi":"https://doi.org/10.1182/blood-2024-204614","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-204614","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2215729572","https://openalex.org/W1996748901","https://openalex.org/W2377458274","https://openalex.org/W2409439928","https://openalex.org/W3217566318","https://openalex.org/W3126730168","https://openalex.org/W2104965094","https://openalex.org/W2063424779","https://openalex.org/W2052365909","https://openalex.org/W3028919400"],"abstract_inverted_index":{"Background:":[0],"SAR442257":[1],"(SAR'257)":[2],"is":[3,44,75],"a":[4,45,76,576,709],"trispecific":[5],"antibody":[6,222],"that":[7,255],"targets":[8],"CD38,":[9],"CD3":[10,14],"and":[11,15,22,39,56,67,71,98,148,158,185,202,224,229,268,283,315,355,379,387,399,454,464,486,491,528,573,617,623,643,649,682,717,730,733],"CD28.":[12],"Simultaneous":[13],"CD28":[16],"binding":[17],"triggers":[18],"T":[19,28,641,646],"cell":[20,647],"co-signaling,":[21],"additional":[23],"CD38":[24,653],"recognition":[25],"directs":[26],"the":[27,51,116,292,325,426,436,476,503,513,533,542,558,588,621,663,670,674,689,715,739,743],"cells":[29,33,642,657],"to":[30,90,218,227,694,721],"CD38+":[31],"cancer":[32],"such":[34],"as":[35,548],"multiple":[36],"myeloma":[37],"(MM)":[38],"non-Hodgkin":[40],"lymphoma":[41],"(NHL).":[42],"This":[43,74,698],"first-in-human":[46],"phase":[47],"1":[48,308,364,446,492,561,574,592,700],"study":[49,81,701,744],"investigating":[50],"safety,":[52],"efficacy,":[53],"pharmacokinetic":[54],"(PK)":[55],"pharmacodynamic":[57],"(PD)":[58],"profile":[59],"of":[60,83,164,193,299,318,415,507,538,568,677,702,712,728,736],"SAR'257":[61,84,106,508,636,703],"in":[62,85,99,115,134,151,230,266,271,281,285,297,307,316,347,356,363,372,376,394,425,435,468,475,532,557,620,692,708,724,738],"patients":[63],"(pts)":[64],"with":[65,87,110,136,153,350,359,385,501,660],"refractory":[66,89,226],"relapsed":[68],"(rr)":[69],"MM":[70],"rrNHL.":[72],"Methods:":[73],"multicenter,":[77],"international,":[78],"open-label,":[79],"dose-escalation":[80],"(NCT04401020)":[82],"pts":[86,100,135,152,169,214,258,265,270,274,301,320,349,358,384,405,500,671,713],"rrMM":[88,137,201,210,250,267,282,300,351,386,398,437,559,622,716],"standard-of-care":[91],"(SOC)":[92],"options,":[93],"including":[94],"anti-CD38":[95,220,228,235,242,665],"monoclonal":[96,221],"antibodies,":[97],"rrNHL":[101,154,207,231,319,360,388,407,427,477,586,624,718],"without":[102],"any":[103,343],"SOC":[104],"options.":[105],"was":[107,196,244,291,370,422,554,590,614,745],"administered":[108],"intravenously":[109],"lead-in":[111],"doses":[112],"(Day":[113],"1\u22125)":[114],"first":[117,534,690],"week,":[118],"followed":[119],"by":[120],"twice":[121],"weekly":[122,126],"(BIW)":[123],"or":[124,511,552,609],"once":[125],"(QW)":[127],"dosing;":[128],"11":[129,311,448],"target":[130],"dose":[131,243,741,748],"levels":[132],"(TDLs)":[133],"(9":[138],"TDLs:":[139,144],"0.06-11":[140],"\u00b5g/kg":[141,146,156,160,312,442,449,458,482,495,526,530,582,600],"BIW;":[142],"2":[143,149,395,455,481,599],"18-27":[145],"QW),":[147],"TDLs":[150,304,327],"(2":[155,479],"BIW":[157,313,443,450,483,527,601],"4":[159,377,441,494],"QW).":[161],"Results:":[162],"As":[163,537],"February":[165],"19,":[166],"2024,":[167,541],"47":[168],"(rrMM,":[170],"n=40;":[171],"rrNHL,":[172],"n=7)":[173],"received":[174],"SAR'257.":[175],"The":[176,190,237,603],"median":[177,191,238],"ages":[178],"(years)":[179],"were":[180,225,234,334,345,433,473,685],"64":[181],"(rrMM;":[182],"range:":[183,188],"40\u221284)":[184],"70":[186],"(rrNHL;":[187],"18\u221275).":[189],"number":[192,711],"prior":[194,216],"lines":[195],"5":[197,203],"(range:":[198,204,246],"3\u221212)":[199],"for":[200,206,249,611],"2\u22127)":[205],"cohort.":[208,251,428],"In":[209,585],"cohort,":[211,587],"all":[212,233,303],"(100%)":[213],"had":[215,259],"exposure":[217],"an":[219,705],"(MAb)":[223],"cohort":[232,408,438,478],"na\u00efve.":[236],"time":[239,661],"from":[240,310,397,406,519,714],"last":[241,664],"2.7":[245],"1\u221265)":[247],"months":[248],"Safety":[252],"analysis":[253,632],"revealed":[254,633],"68%":[256],"(n=32)":[257],"treatment-emergent":[260],"adverse":[261],"events":[262],"(TEAEs;":[263],"26":[264],"6":[269],"rrNHL);":[272],"21.3%":[273],"(n=10)":[275],"Grade":[276],"(G)":[277],"\u22653":[278],"TEAEs":[279],"(7":[280],"3":[284],"rrNHL).":[286],"Cytokine":[287],"release":[288],"syndrome":[289,420],"(CRS)":[290],"most":[293],"common":[294],"TEAE,":[295],"occurring":[296],"52.5%":[298],"across":[302],"(n=21;":[305],"G\u22653":[306,362,375,393],"pt":[309,562,593],"TDL)":[314],"57.1%":[317],"(n=4;":[321],"no":[322,353,382],"G\u22653)":[323,354,383],"at":[324,337,440,447,456,480,493,524,580,598],"two":[326],"tested.":[328],"Repetitive":[329],"CRS":[330,737],"episodes":[331,735],"(>1":[332],"episode)":[333],"more":[335],"frequent":[336],"higher":[338,687,740],"TDLs.":[339],"Infusion-related":[340],"reactions":[341],"(IRRs;":[342],"G)":[344],"observed":[346,434,474],"22.5%":[348],"(n=9;":[352],"28.5%":[357],"(n=2;":[361,381],"pt).":[365],"Epstein-Barr":[366],"virus":[367],"(EBV)":[368],"infection/reactivation":[369],"reported":[371,409,423],"17.5%":[373],"(n=7;":[374],"pts)":[378,396],"28.6%":[380,618],"respectively.":[389,626],"Further,":[390],"15%":[391],"(n=6,":[392],"14.3%":[400],"(n=1;":[401],"G2":[402],"CMV":[403,461,731],"reactivation)":[404],"cytomegalovirus":[410],"(CMV)":[411],"infection/reactivation.":[412],"One":[413],"case":[414],"immune":[416],"effector":[417],"cell-associated":[418],"neurotoxicity":[419],"(ICANS)":[421],"(G4)":[424],"Four":[429],"dose-limiting":[430],"toxicities":[431],"(DLTs)":[432],"[1":[439],"(G3":[444,460],"hepatotoxicity);":[445],"(G5":[451],"CRS\u2212EBV":[452],"reactivation;":[453],"27":[457,581],"QW":[459,496,531,583],"infection":[462],"reactivation":[463,732],"G3":[465],"febrile":[466],"neutropenia":[467,485],"same":[469,489],"pt)].":[470],"Three":[471],"DLTs":[472],"[G4":[484],"G4":[487],"thrombocytopenia;":[488],"pt]":[490],"[ICANS":[497],"G4]).":[498],"For":[499,627],"rrMM,":[502],"maximum":[504],"plasma":[505,656],"concentration":[506],"reached":[509],"within":[510],"above":[512],"theoretical":[514],"efficacious":[515],"range":[516],"(0.1\u22121nM;":[517],"extrapolated":[518],"ex":[520],"vivo":[521],"models),":[522],"starting":[523],"8":[525],"18":[529],"treatment":[535,637],"cycle.":[536],"July":[539],"08,":[540],"overall":[543],"response":[544,550,566,569,578,707],"rate":[545,606],"(ORR),":[546],"defined":[547],"partial":[549],"(PR)":[551],"better,":[553],"5%":[555],"(n=2)":[556,619],"cohort:":[560],"exhibited":[563],"stringent":[564],"complete":[565,577],"(duration":[567],"[DOR]=8.1":[570],"months,":[571],"on-going)":[572],"showed":[575,704],"(CR)":[579],"TDL.":[584,602],"ORR":[589],"14.3%,":[591],"achieved":[594],"PR":[595],"(DOR=7.1":[596],"months)":[597],"disease":[604,608],"control":[605],"(stable":[607],"better":[610],">8":[612],"weeks)":[613],"60%":[615],"(n=24)":[616],"cohorts":[625,629],"both":[628],"exploratory":[630],"biomarker":[631],"that:":[634],"(1)":[635],"activated":[638],"peripheral":[639],"blood":[640],"reduced":[644],"regulatory":[645],"numbers":[648],"CD4/CD8":[650],"ratio;":[651],"(2)":[652],"expression":[654],"on":[655],"positively":[658],"corelated":[659],"since":[662],"MAb":[666],"dose;":[667],"(3)":[668],"Among":[669],"experiencing":[672],"CRS,":[673],"peak":[675],"values":[676],"cytokines":[678],"(Interleukin":[679],"(IL)-6,":[680],"IL-8,":[681],"C-reactive":[683],"protein)":[684],"significantly":[686],"during":[688,747],"cycle":[691],"comparison":[693],"subsequent":[695],"cycles.":[696],"Conclusion:":[697],"Phase":[699],"anti-tumor":[706],"small":[710],"cohorts.":[719],"Due":[720],"safety":[722],"concerns,":[723],"particular":[725],"high":[726],"rates":[727],"EBV":[729],"recurrent":[734],"levels,":[742],"terminated":[746],"escalation.":[749]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}